Annals of Epidemiology
Volume 11, Issue 3 , Pages 166-170 , April 2001

β-Fibrinogen Gene −455G/A Polymorphism and Coronary Heart Disease Incidence: The Atherosclerosis Risk in Communities (ARIC) Study

  • Aaron R Folsom, MD

      Affiliations

    • Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, MN (A.R.F.); Division of Hematology (N.A., K.K.W.) and Section of Clinical Epidemiology (C.A.), University of Texas Medical School, Houston, TX USA
    • and Human Genetics Center and Institute of Molecular Medicine, University of Texas, Houston Health Science Center, Houston, TX (E.B.) USA.
    • Corresponding Author InformationAddress reprint requests to: Aaron R. Folsom, M.D., Division of Epidemiology, School of Public Health, University of Minnesota, Suite 300, 1300 South Second Street, Minneapolis, Minnesota 55454–1015
    • ,
  • Nena Aleksic, PharmD, PhD

      Affiliations

    • Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, MN (A.R.F.); Division of Hematology (N.A., K.K.W.) and Section of Clinical Epidemiology (C.A.), University of Texas Medical School, Houston, TX USA
    • and Human Genetics Center and Institute of Molecular Medicine, University of Texas, Houston Health Science Center, Houston, TX (E.B.) USA.
    • ,
  • Chul Ahn, PhD

      Affiliations

    • Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, MN (A.R.F.); Division of Hematology (N.A., K.K.W.) and Section of Clinical Epidemiology (C.A.), University of Texas Medical School, Houston, TX USA
    • and Human Genetics Center and Institute of Molecular Medicine, University of Texas, Houston Health Science Center, Houston, TX (E.B.) USA.
    • ,
  • Eric Boerwinkle, PhD

      Affiliations

    • Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, MN (A.R.F.); Division of Hematology (N.A., K.K.W.) and Section of Clinical Epidemiology (C.A.), University of Texas Medical School, Houston, TX USA
    • and Human Genetics Center and Institute of Molecular Medicine, University of Texas, Houston Health Science Center, Houston, TX (E.B.) USA.
    • ,
  • Kenneth K Wu, MD

      Affiliations

    • Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, MN (A.R.F.); Division of Hematology (N.A., K.K.W.) and Section of Clinical Epidemiology (C.A.), University of Texas Medical School, Houston, TX USA
    • and Human Genetics Center and Institute of Molecular Medicine, University of Texas, Houston Health Science Center, Houston, TX (E.B.) USA.

References 

  1. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501–505
  2. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, et al.  Haemostatic function and ischaemic heart disease (Principal results of the Northwick Park Heart Study). Lancet. 1986;2:533–537
  3. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease (The Framingham Study). JAMA. 1987;258:1183–1186
  4. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease (The Atherosclerosis Risk in Communities (ARIC) Study). Circulation. 1997;96:1102–1108
  5. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease (Meta-analyses of prospective studies). JAMA. 1998;279:1477–1482
  6. Thomas A, Lamlum H, Humphries S, Green F. Linkage disequilibrium across the fibrinogen locus as shown by five genetic polymorphisms, G/A−455 (HAEIII), C/T148 (HindIII/AluI), T/G+1689 (AvaIII), and BclI (β-Fibrinogen) and TaqI (α-Fibrinogen), and their detection by PCR. Human Mutation. 1994;3:79–81
  7. Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW, et al.  Variation in the promoter region of the beta fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost. 1991;65:487–490
  8. Green F, Hamsten A, Blombäck M, Humphries S. The role of β-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost. 1993;70:915–920
  9. Scarabin P-Y, Bara L, Ricard S, Poirier O, Cambou JP, Arveiler D, et al.  Genetic variation at the β-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb. 1993;13:886–891
  10. Behague I, Poirier O, Nicaud V, Evans A, Arveiler D, Luc G, et al. β fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Circulation. 1996;93:440–449.
  11. Gardemann A, Schwartz O, Haberbosch W, Katz N, Weiss T, Tillmanns H, et al.  Positive association of the β fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction. Thromb Haemost. 1997;77:1120–1126
  12. de Maat MPM, Kastelein JJP, Jukema JW, Zwinderman AH, Jansen H, Groenemeier B, et al.  −455G/A polymorphism of the β-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men. Proposed role for an acute-phase reaction pattern of fibrinogen. Arterioscler Thromb Vasc Biol. 1998;18:265–271
  13. van der Bom JG, de Maat MPM, Bots ML, Haverkate F, de Jong PTVM, Hofman A, et al.  Elevated plasma fibrinogen. Cause or consequence of cardiovascular disease?. Arterioscler Thromb Vasc Biol. 1998;18:621–625
  14. Tybjaerg-Hansen A, Agerholm-Larsen B, Humphries SE, Abildgaard S, Schnohr P, Nordestgaard BG. A common mutation (G−455→A) in the β-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study. J Clin Invest. 1997;99:3034–3039.
  15. Thomas AE, Green FR, Humphries SE. Association of genetic variation at the β-fibrinogen gene locus and plasma fibrinogen levels; interaction between allele frequency of the G/A−455 polymorphism, age and smoking. Clin Genet. 1996;50:184–190
  16. Heinrich J, Funke H, Rust S, Schulte H, Schönfeld R, Köhler E, et al.  Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients. Thromb Res. 1995;77:209–215
  17. Iso H, Folsom AR, Winkelmann JC, Koike K, Harada S, Greenberg B, et al.  Polymorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples. Thromb Haemost. 1995;73:106–111
  18. Lee AJ, Fowkes FG, Lowe GD, Connor JM, Rumley A. Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis (Edinburgh Artery Study). Thromb Haemost. 1999;81:553–560
  19. Humphries SE, Ye S, Talmud P, Bara L, Wilhelmsen L, Tiret L. European Atherosclerosis Research Study (Genotype at the fibrinogen locus (G−455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence for gender-genotype-environment interaction). Arterioscler Thromb Vasc Biol. 1995;15:96–104
  20. Connor JM, Fowkes FGR, Wood J, Smith FB, Donnan PT, Lowe GDO. Genetic variation at fibrinogen loci and plasma fibrinogen levels. J Med Genet. 1992;29:480–482
  21. Carter AM, Mansfield MW, Stickland MH, Grant PJ. β-fibrinogen gene −455G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM. Diabetes Care. 1996;19:1265–1268
  22. The ARIC Investigators . The Atherosclerosis Risk in Communities (ARIC) Study (Design and objectives). Am J Epidemiol. 1989;129:687–702
  23. Jackson R, Chambless LE, Yang K, Byrne T, Watson R, Folsom A, et al.  Differences between respondents and nonrespondents in a multicenter community-based study vary by gender and ethnicity. J Clin Epidemiol. 1996;49:1441–1446
  24. Bond MG, Barnes R, Riley WA, Wilmoth SK, Chambless LE, Howard G, et al.  High resolution β-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities Study (ARIC). J Neuroimag. 1991;1:68–73
  25. Riley WA, Barnes R, Bond MG, Evans GW, Chambless L, Heiss G. High resolution β-mode ultrasound reading methods in the Atherosclerosis Risk in Communities Study (ARIC). J Neuroimag. 1991;1:168–172
  26. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957;17:237–246
  27. Siedel J, Hegele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of total serum cholesterol with improved lipolytic efficiency. Clin Chem. 1983;29:1075–1080
  28. Nagele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, et al.  Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem. 1984;22:165–174
  29. Warnick GR, Benderson JM, Albers JJ. Quantitation of high-density-lipoprotein subclasses after separation by dextran sulfate and Mg2+ precipitation. Clin Chem. 1982;28:1574
  30. White AD, Folsom AR, Chambless LE, Sharrett AR, Yang K, Conwill D, et al.  Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study (Methods and initial two years' experience). J Clin Epidemiol. 1996;49:223–233
  31. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings (Standards and Procedures for Measurement and Classification). Littleton, MA: John Wright; 1982;
  32. Barlow WE. Robust variance estimation for the case-cohort design. Biometrics. 1994;50:1064–1072
  33. Brown ET, Fuller GM. Detection of a complex that associates with the Bβ fibrinogen G−455-A polymorphism. Blood. 1998;92:3286–3293
  34. Fowkes FGR, Connor JM, Smith FB, Wood J, Donnan PT, Lowe GDO. Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet. 1992;339:693–696
  35. Zito F, Di Castelnuovo A, Amore C, D'Orazio A, Donati MB, Iacoviello L. Bcl I polymorphism in the fibrinogen β-chain gene is associated with the risk of familial myocardial infarction by increasing plasma fibrinogen levels. A case-control study in a sample of GISSI-2 patients. Arterioscler Thromb Vasc Biol. 1997;17: 3489–3494.

PII: S1047-2797(00)00203-9

Annals of Epidemiology
Volume 11, Issue 3 , Pages 166-170 , April 2001

Article Tools